Comparator Study of LT-NS001 in Healthy Subjects With Endoscopic Evaluation

• Status: Completed
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare naproxen plasma levels and gastroduodenal mucosal injury after administration of LT-NS001 as compared to Naprosyn in subjects age 45-70.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Logical Therapeutics
• Treatments: Naproxen

Criteria

Inclusion Criteria:

• BMI 18-30 kg/m2

• No NSAID's for 14 days prior to baseline endoscopy

Exclusion Criteria:

• Pregnant/Nursing women

• History of documented gastroduodenal ulcer